Inpatient and Outpatient Orderable

OnkoSight Advanced Chronic Lymphoid Neoplasm Build info

Synonyms

  • ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASM
  • ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA NGS
  • OSACLN
  • ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA N
  • LAB12276

Procedure Name

ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASM

Procedure Master Number

LAB12276

Procedure ID

137023

Clinical Info


This test includes the following genes: ARID1A, ATM, B2M, BCL2, BIRC3, BRAF, BTK, CARD11, CCND1, CCND3,
CD79B, CDKN2A, CREBBP, CXCR4, DNMT3A, EP300, EZH2, FBXW7, FOXO1, IDH2, IRF4, JAK1, JAK3, KRAS, 
MAP2K1, MAPK1, MEF2B, MYC, MYD88, NOTCH1, NOTCH2, NRAS, NSD2, PIK3CD, PIM1, PLCG2, PRDM1, 
RHOA, SETD2, SF3B1, SOCS1, STAT3, STAT5B, STAT6, TCF3, TET2, TNFAIP3, TNFRSF14, TP53 and XPO1.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow Aspirate

Specimen Types

 Aspirate Blood Bone Marrow

Container

Lavender Top Tube

Collection Instructions


Container
Lavender-top (EDTA) tube; green-top (sodium heparin) tube; cells left over from flow cytometry analysis,
either fresh cell suspension or fresh/frozen cell pellet spun down from suspension.
Cell suspension should be shipped on ice.
Causes for Rejection
Specimen does not meet criteria for sample type, container, minimum volume, collection and storage; frozen whole blood 
or marrow; leaking tube; clotted blood or marrow; grossly hemolyzed specimen or otherwise visibly degraded; contaminated 
specimen; contains suspicious foreign material

Specimen Volume


Volume
3-5 mL (blood), 1-2 mL (bone marrow)
Minimum Volume
3 mL (blood), 1 mL (bone marrow)

Transport Instructions

Room Temperature

Specimen Stability

Methodology


The Labcorp Myeloid NGS assay utilizes capture-based next generation sequencing of whole genomic DNA libraries
to identify gene alterations that have diagnostic, prognostic and therapeutic significance in lymphoid malignancies.

Days Performed

TAT: 10-14 Days

Performing Laboratory

Labcorp

CPT

81450

PDM

 235442

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP ONKOACHLYM ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP OnkoSight Advanced Chronic Lymphoid Neop
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic and Prognostic Associations
INTERPRETATION SUMMARY ONKOSIGHTINT INTERPRETATION SUMMARY Interpretation Summary
DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1
DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 :
CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1 :
CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2 :
TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary :
METHODS METHODS METHODS Methods
REFERENCES 1 REF1 REFERENCES 1 References 1
REFERENCES 2 REF2 REFERENCES 2 References 2
REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer
ADDENDUM : ADDENDUM ADDENDUM Addendum :

Result Interpretation

See Report

Forms
edit